• Font Size    
E-mail

Close Window E-mail This Page

$600K Given To City Of Hope Breast Cancer Research

Required fields are marked with an asterisk(*)



The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +

$600K Given To City Of Hope Breast Cancer Research

  City of Hope received a three-year grant totaling $600,000 from the Susan G. Komen for the Cure today to fund research on the side effects of hormone-dependent breast cancer.

Researchers will use the money to determine how to reduce the side
effects of aromatase inhibitors -- typically joint pain, bone loss and
fractures -- which are used to fight cancer in postmenopausal women. Patients undergoing long-term treatment can also develop a resistance to aromatase inhibitors.

A drug known as LBH589 may prevent side effects and drug resistance.

"The Susan G. Komen for the Cure grant will help us understand how
LBH589 works and explore whether a combination of typical aromatase inhibitors with this drug will produce a synergistic effect," said Shiuan Chen, director of Tumor Cell Biology, Beckman Research Institute at City of Hope.

You need the latest Flash player to view video content.
Click here to download.

Click here to bypass this detection if you already have the latest Flash Player.